The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients
- 12 July 2017
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 10 (9) , 821-832
Abstract
Despite lack of knowledge in the field, several studies have underlined the role of endothelium dysfunction and platelet activation as significant players in the development and progression of chronic obstructive pulmonary disease (COPD). Indeed, endothelium plays a crucial role in vascular homeostasis and impairment, due to the inflammation process enhanced by smoking. Chronic inflammation and endothelial dysfunction have been proved to drive platelet activity. Consequently, thrombotic risk is enhanced in COPD, and might explain the higher percentage of cardiovascular death in such patients. Areas covered: This review aims to clarify the role of endothelium function and platelet hyper-activity as the pathophysiological mechanisms of the increased thrombotic risk in COPD. Expert commentary: In COPD patients, chronic inflammation does not impact only on lung parenchyma, but potentially involves all systems, including the endothelium of blood vessels. Impaired endothelium has several consequences, such as reduced vasodilatation capacity, enhanced blood coagulation, and increased platelet activation resulting in higher risk of thrombosis in COPD patients. Endothelium dysfunction and platelet activation are potential targets of therapy in patients with COPD aiming to reduce their risk of cardiovascular events.Keywords
This publication has 173 references indexed in Scilit:
- Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary DiseaseJAMA, 2013
- Pharmacological antioxidant strategies as therapeutic interventions for COPDBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Nitric oxide synthases: regulation and functionEuropean Heart Journal, 2011
- Circulating Endothelial Microparticles as a Measure of Early Lung Destruction in Cigarette SmokersAmerican Journal of Respiratory and Critical Care Medicine, 2011
- β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary DiseaseArchives of internal medicine (1960), 2010
- Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in a Population-Based StudyCirculation, 2009
- Immune and Inflammatory Mechanisms of AtherosclerosisAnnual Review of Immunology, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Predictive Value of Reactive Hyperemia for Cardiovascular Events in Patients With Peripheral Arterial Disease Undergoing Vascular SurgeryArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Prostacyclin Prevents Pulmonary Endothelial Cell Apoptosis Induced by Cigarette SmokeAmerican Journal of Respiratory and Critical Care Medicine, 2007